Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600127824Phase 4Recruiting
Phase 4, randomised trial of oliceridine in ureterolithiasis, cystolithiasis, urethral calculus and 4 more (2 arms), sponsored by Jiangmen Central Hospital. Primary endpoint: Quality of recovery on the first postoperative day (QoR-15). Started Jul 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600127824.